It will mostly be the major domestic players and MNCs that will thrive in China's infant formula market in the upcoming years, claim experts, citing a raft of reasons such as a more stringent regulatory environment, negative population growth, and an under-performing economy as hurdles for other firms.
GALLERY: The 10 most-read APAC health and nutrition stories in May 2023
Regulatory review: Latest nutra updates from India, China, South Korea
From pharma to lifestyle nutrition: Singapore firm launches day and night dual sleep and energy supplement
Safety first: Latest updates from Australia, India, South Korea in safeguarding nutraceutical safety
